View Rule
| View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
| HHS/HRSA | RIN: 0906-AB08 | Publication ID: Spring 2017 |
| Title: 340B Program Omnibus Guidelines | |
|
Abstract:
This guidance addresses key policy issues raised by stakeholders for which HHS does not have statutory rulemaking authority. |
|
| Agency: Department of Health and Human Services(HHS) | Priority: Other Significant |
| RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Completed Actions |
| Major: No | Unfunded Mandates: No |
| CFR Citation: None (To search for a specific CFR, visit the Code of Federal Regulations.) | |
| Legal Authority: Not Yet Determined | |
|
Legal Deadline:
None |
||||||||||||
Timetable:
|
| Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
| Small Entities Affected: No | Federalism: No |
| Included in the Regulatory Plan: Yes | |
| RIN Data Printed in the FR: No | |
|
Agency Contact: Krista Pedley Director, Office of Pharmacy Affairs Department of Health and Human Services Health Resources and Services Administration Healthcare Systems Bureau, 5600 Fishers Lane, Rockville, MD 20857 Phone:301 594-4353 Email: krista.pedley@hrsa.hhs.gov |
|
An official website of the United States government



